TGFB1 and Peritoneal Fibrosis: In this study, we demonstrated that the expression of miR‐302c was decreased in both PD patients and a human peritoneal cell line treated with TGF‐β1; additionally, miR‐302c was negatively correlated with MMT and peritoneal fibrosis.